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We compared phenotypes of ﬁve strains ofMycobacterium tuberculosis (Mtb) differing in their expression
of rv1248c and its product, 2-hydroxy-3-oxoadipate synthase (HOAS), with a focus on carbon source-
dependent growth rates and attenuation in mice. Surprisingly, an rv1248c transposon mutant on a
CDC1551 background grew differently than an rv1248c deletion mutant on the same background.
Moreover, the same rv1248c deletion in two different yet genetically similar strain backgrounds
(CDC1551 and H37Rv) gave different phenotypes, though each could be complemented. Whole genome
re-sequencing did not provide an obvious explanation for these discrepancies. These observations offer a
cautionary lesson about the strength of inference from complementation and sequence analysis, and
commend consideration of more complex phenomena than usually contemplated in Mtb, such as
epigenetic control.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
As tuberculosis (TB) continues to impose a devastating global
burden, drug discovery efforts put a premium on characterization
of annotated and orphan genes implicated in pathways vital for
survival of Mycobacterium tuberculosis (Mtb) [1]. Transposon
insertion mutagenesis is a powerful tool used to identify genetic
elements that are essential for bacterial growth and pathogenesis
[2]. Himar-1 transposon mutagenesis libraries generated in an Mtb
H37Rv background suggested that rv1248c (hoas), the gene that
encodes 2-hydroxy-3-oxoadipate synthase (HOAS), may be essen-
tial for in vitro growth [3e5]. HOAS, a thiamin diphosphate (ThDP)-
dependent enzyme, functions at a node linking the tricarboxylic
acid (TCA) cycle and glutamate synthesis through its substrate, a-
ketoglutarate (a-KG). HOAS is multifunctional through its ability to
convert a-KG to succinyl-CoA, succinyl semialdehyde (SSA), andan).
Ltd. This is an open access article uhydroxy-oxoadipate (HOA); HOA spontaneously gives rise to 5-
hydroxylevulinc acid (HLA) [6]. Recombinant HOAS has been
extensively studied in vitro, but characterization of the enzyme's
function in the intact cell requires studies of cells bearing mutant
alleles of rv1248c.
A transposon mutant, hoas::tnCDC1551, was generated in a wild-
type CDC1551 (WTCDC1551) strain background as part of the
Tuberculosis Animal Research and Gene Evaluation Taskforce
(TARGET) initiative. Its existence suggested that HOAS is dispens-
able for growth of Mtb in vitro [7]. CDC1551 caused a TB outbreak
near the KentuckyeTennessee border in the mid 1990s and was
initially considered hypervirulent in humans [8]. Studies of
CDC1551 in mice found it to be less virulent than [9] or comparable
in virulence to the laboratory strain H37Rv [10,11].
We began assessing the role of HOAS in Mtb by comparing the
phenotype of WTCDC1551 and hoas::tnCDC1551. While that work was
underway, we used the WTCDC1551 parent to generate the deletion
mutant described below, termed DhoasCDC1551. We characterized
the in vitro growth of DhoasCDC1551 and hoas::tnCDC1551 in media
with deﬁned carbon sources and compared it to the behavior ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Characterization in vitro of Mtb strains with hoas deleted or disrupted by transposon insertion. (A) Immunoblot of HOAS in lysates of WTCDC1551, hoas::tnCDC1551,
DhoasCDC1551, hoas::tnCDC1551::hoas, and DhoasCDC1551::hoas using antiserum against HOAS. Antiserum against DlaT was used as a loading control. (BeE) Growth curves of WTH37Rv,
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termed DhoasH37Rv, as reported elsewhere [12]. Surprisingly, the
phenotypes of all three strains varied, even though all phenotypes
but one were reverted to wild type by complementation with a
full-length, wild type hoas allele. Whole-genome sequencing
identiﬁed polymorphisms unique to each mutant and its WT
parent but did not offer an apparent explanation for the divergent
phenotypes.
2. Materials and methods
2.1. Mtb culture and generation of mutants
Standard liquid and agar culture methods, composition of Sau-
ton's minimal medium (SMM), and growth experiments in carbon-
deﬁned Sauton's minimal medium were as described [12].
Procedures for engineering DhoasH37Rv and its complementation
with a full length hoas allele (DhoasH37Rv::hoas) were as described
[12]. For DhoasCDC1551, hoas was cloned downstream of an hsp60
promoter into pDE43-MCS via Gateway Cloning Technology (Invi-
trogen) to yield pDE43hsp60hoas-MCS, which integrates into the
attL5 site. This vector was electroporated into competentWTCDC1551
to create merodiploidWTCDC1551::hoas. This merodiploid strainwas
transformed with the nitrile-inducible recombineering plasmid
pNIT(kan)::RecET-sacB, and colonies were selected on 7H10 agar
plates with 10 ug/mL streptomycin and 15 ug/mL kanamycin.
Replacement of native hoaswith a hygromycin cassette was carried
out by methods described in [12]. Knockout candidates
(DhoasCDC1551::pGMCS-hsp60hoas) were screened for kanamycin
sensitivity, implicating loss of pNIT(kan)::RecET-sacB, and native
hoas deletionwas conﬁrmed by Southern blot. To test essentiality of
hoas, a plasmid harboring a zeocin resistance gene, pGMZq17-0X-
0X, was transformed into competent DhoasCDC::pGMCS-hsp60hoas.
DhoasCDC1551::pGMZq17-0X-0X (here called DhoasCDC1551) candi-
dates were isolated on 7H10 agar with 50 ug/mL hygromycin and
25 ug/mL zeocin and further screened by immunoblot. Plasmids
pDE43-MCS and pGMZq17-0X-0X were a kind gift from Dirk
Schnappinger, Weill Cornell Medical College and plasmid pNIT(-
kan)::RecET-sacB was from Kenan Murphy and Christopher Sas-
setti, University of Massachusetts.
2.2. Other procedures
Protocols for immunoblotting and Mtb aerosol infection of mice
were as reported in [12].
2.3. Whole genome sequencing
The genomes of the ﬁve strains described in this study were
sequenced using next-generation sequencing technology. Three of
the strains were sequenced using an Illumina HiSeq 2500 with a
read length of 54 bp, and the other two were sequenced using an
Illumina MiSeq with a read length of 150 bp. The machines were
operated in paired end mode. All samples were prepared according
to the standard Illumina genomic DNA sample preparation protocol
(Illumina, Inc.). The sequencing statistics, including read-length
and depth of coverage for each sample are given in Table S1.
Genome sequences were assembled by a comparative method as
described in [13], using published genomes for H37Rv and CDC1551
as reference sequences.DhoasH37Rv, and DhoasH37Rv::hoas in modiﬁed Sauton's minimal medium supplemented with
(FeI) Growth curves of WCDC1551, DhoasCDC1551, DhoasCDC1551::hoas, hoas::tnCDC1551, and hoas
glycerol, (G) acetate, (E) glutamate, or (I) glutamate and acetate, each at 0.2%. All results ar3. Results
3.1. Generation and complementation of hoas mutant strains on the
CDC1551 background
Immunoblot with rabbit antiserum against puriﬁed recombi-
nant HOAS demonstrated that hoas::tnCDC1551 expresses a truncated
variant of HOAS (Figure 1A). This was consistent with the distal
insertion of Himar-1, which introduced a premature stop codon at
nucleotide 3568, resulting in a putative 42 amino acid truncation at
the C-terminus of this 1231-residue protein. To explore the essen-
tiality of hoas in Mtb, we introduced a full-length hoas allele into
the attL5 site of WTCDC1551 Mtb, generating a merodiploid variant.
We replaced native hoas with a hygromycin resistance cassette by
allelic exchange via recombineering. By subsequently replacing the
attL5 copy of hoas with a vector conferring zeocin resistance, we
generated DhoasCDC1551. Deletion of the gene was conﬁrmed by
Southern blot (Figure S1) and by absence of the protein on
immunoblot (Figure 1A). Generation of DhoasCDC1551 established
that hoas is not essential for in vitro growth of Mtb in standard 7H9
complete medium.
To test if phenotypes of hoas::tnCDC1551 and DhoasCDC1551 were
due to disruption of hoas, we complemented both strains with the
full length hoas allele under the control of a constitutive hsp60
promoter. Complementation restored HOAS protein toWT levels in
both mutants (Figure 1A).
3.2. Growth on deﬁned carbon sources
We next compared the in vitro growth proﬁles of hoas::tnCDC1551,
DhoasCDC1551, and DhoasH37Rv in a modiﬁed Sauton's minimal me-
dium supplemented with a single carbon source or a combination
of two carbon sources. Deletion mutants DhoasCDC1551 and
DhoasH37Rv grew no less rapidly than their respective WT parental
strains when cultured in either glycerol or acetate (Figure 1B and C,
F and G). However, as reported elsewhere [12] and recapitulated
here, glutamate, either as sole carbon source or in combination
with glycerol or acetate in equal amounts by weight, greatly sup-
pressed growth of DhoasH37Rv (Figure 1D and E). In striking
contrast, DhoasCDC1551 grew as well as WTCDC1551 with glutamate as
sole carbon source (Figure 1H). Nonetheless, growth of
DhoasCDC1551 was abolishedwhen acetate, permissive for growth on
its own, was added along with glutamate (Figure 1I). On the other
hand, and again in striking contrast to results for DhoasH37Rv,
glycerol (as opposed to glutamate) stalled hoas::tnCDC1551 growth
for approximately 20 days (Figure 1F). Moreover, growth of
hoas::tnCDC1551, like growth of DhoasCDC1551, was suppressed when
glutamate was combined with acetate (Figure 1I). Complementa-
tion with full length HOAS in hoas::tnCDC1551, DhoasH37Rv, and
DhoasH37Rv, generating hoas::tnCDC1551::hoas, DhoasCDC1551::hoas,
and DhoasH37Rv::hoas, respectively, rescued all their observed
growth defects, with one exception: the suppression of growth of
hoas::tnCDC1551::hoas in glycerol (Figure 1F).
3.3. Course of infection in mice
Next, we infected C57BL/6 mice with approximately 100 colony
forming units of bacteria per lung of aerosolized WTCDC1551,
DhoasCDC1551, or DhoasCDC1551::hoas. At day 14, DhoasCDC1551 grew to
a level of CFU in lungs that was about 0.5 log10 units lower than theeither (B) glycerol, (C) acetate, (D) glutamate, or (E) glutamate and acetate, each at 0.2%.
::tnCDC1551::hoas in modiﬁed Sauton's minimal medium supplemented with either (F)
e representative of at least three experiments.
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14 and 28 and then declined, so that by day 62, no DhoasCDC1551
colonies were recovered from mouse lungs after minimal dilution
of the organ homogenate, such that the limit of detection was only
10 CFU (Figure 2). Thus, deletion of hoas in the CDC1551 back-
ground severely attenuated Mtb in vivo, and this defect was com-
plemented by the WT allele. As noted elsewhere, DhoasH37Rv was
attenuated in the mouse as well [12], but not as severely as seen
here for DhoasCDC1551. Moreover, WTH37Rv established much higher
CFU levels than WTCDC1551, for which only about 104 CFU were
recovered, similar to results in another study [9].
3.4. Whole genome re-sequencing
In an effort to understand the discrepancies in the growth
phenotypes observed between hoas::tnCDC1551, DhoasCDC1551, and
DhoasH37Rv, and the low bacillary loads of WTCDC1551 in mouse
lungs, we re-sequenced the genomes of ﬁve strains: WTCDC1551,
DhoasCDC1551, hoas::tnCDC1551, WTH37Rv and DhoasH37Rv (Table 1).
WTH37Rv and DhoasH37Rv harbored mutations relative to theFigure 2. Phenotype in mice of WT, hoas-deleted and hoas-disrupted Mtb strains
on the CDC1551 background. Bacterial CFU counts in lungs of mice infected with
WTCDC1551, DhoasCDC1551, or DhoasCDC1551::hoas. Data are means ± SEM for ﬁve mice per
time point (four on day 1). Dashed line indicates the limit of detection. For
DhoasCDC1551 no colonies were recovered at day 62.
Table 1
Results of whole genome re-sequencing. Identiﬁedmutations inWTCDC1551, DhoasCDC155
strains. Boldface indicates polymorphisms that are unique; non-boldfaced polymorphis
Strain Polymorphisms
WTCDC1551 rv2672:R320Q
rv3303c: þA (1 bp ins) in T410
DhoasCDC1551 rv1248c
rv2932: -T (frameshift in aa 420/1538)
rv3919c: G37R
rv2672:R320Q
rv3303c: þA (1 bp ins) in T410










Boldface indicates polymorphisms that are unique; non-boldface polymorphisms are shpublished H37Rv sequence (NC_000962.3) that were also shared
among ﬁve other laboratory strains, and, in particular, were most
similar to the strain H37RvCO [13]. In terms of novel mutations,
both WTH37Rv and DhoasH37Rv share a non-synonymous mutation
M69L in Rv0516c (possible antieanti sigma factor). In addition, the
WTH37Rv strain had two other unique mutations not found in the
deletion mutant. These included a frameshift in residue 1242 of
rv2932 (ppsB, component of type I polyketide synthase) and H80Q
in Rv0505c (serB1, phosphoserine phosphatase). These were most
likely acquired in the parental stock subsequent to generation of
the deletion mutant, as H37Rv/pNIT(kan):RecET-SacB [12] was
plated on sucrose to ensure the loss of the recombineering plasmid.
The only unique mutation identiﬁed in the DhoasH37Rv mutant,
other than deletion of rv1248c, was a novel insertion of the trans-
posable element IS6110 in rv1358 (supplementary to the 16 known
insertion sites in H37Rv). rv1358 is a transcription factor whose role
is currently unknown. The growth impairment observed on gluta-
mate for the DhoasH37Rv strain, compared to the parental strain
(H37Rv), is most likely explained by the deletion of the HOAS gene,
because it could be complemented with the WT allele of rv1248c.
The hoas::tnCDC1551 and DhoasCDC1551 mutants each exhibited
several unique polymorphisms compared to the parentalWTCDC1551
sequence. The transposon-insertion mutant, hoas::tnCDC1551, had
unique SNPs in rv0472c (A24A), MT1802 (P167A), and rv1812c
(V279L). The mutation in rv0472c is synonymous and hence pre-
sumably silent. Rv1812c is annotated as a dehydrogenase but its
substrates are unknown. MT1801, annotated as a molybdopterin
oxidoreductase, is encoded in a region of the CDC1551 genome that
is deleted from H37Rv. It is not apparent how mutations in either
enzyme might impart sensitivity to glycerol or avoid the growth
inhibitory effect of glutamate, as compared to DhoasH37Rv.
As noted, the recombineered deletionmutant, DhoasCDC1551, was
also able to grow on glutamate (unlike DhoasH37Rv), and its growth
defect on glutamate plus acetate was only rescued by comple-
mentation after a delay that was not observed in DhoasH37Rv.
However, after ﬁltering out mutations shared between the parental
CDC1551 strain and the deletion mutant, and discounting the effect
of the frameshift in ppsB (which should only affect PDIM biosyn-
thesis), the only unique mutation left in the DhoasCDC1551 mutant
was G37R in rv3919c (gidB). The latter SNP is unlikely to explain the
growth phenotype, as GidB is an rRNA methyltransferse. The mu-
tation is potentially due to selection on streptomycin during the
mutant generation protocol, as mutations in gidB are often found to
confer streptomycin resistance [14].1, hoas::tnCDC1551, WTH37Rv and DhoasH37Rv that differ from their respective reference
ms are shared between two or more strains.
Annotation
Possible secreted protease
LpdA: NAD(P)H quinone reductase
HOAS
PpsB: Pthiocerol synthesis type-I polyketide synthase
GidB: rRNA methyltransferase
Possible secreted protease
LpdA: NAD(P)H quinone reductase
HOAS
Probable TetR-family transcription factor
Probable dehydrogenase
Molybdopterin Oxidoreductase (not present in H37Rv)
Possible antieanti sigma factor
SerB1: Phosphoserine phosphatase
PpsB: Phthiocerol synthesis type-I polyketide synthase
HOAS
Possible antieanti sigma factor
Probable transcription factor
ared between two or more strains. Italics is a standard way to indicate genes.
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unique polymorphisms not observed in other stocks of CDC1551,
such as the transposon insertionmutant hoas::tnCDC1551 (whichwas
generated in a different lab). These include a SNP in Rv2672
(possible secreted protease) and a frameshift in LpdA. It is possible
that these SNPs are related to the relative attenuation of the
WTCDC1551 and DhoasCDC1551 strains in mice, compared to the
bacillary loads typically achieved by H37Rv-derived strains. How-
ever, since these SNPs are shared by DhoasCDC1551 and WTCDC1551,
they should not have any bearing on the in vitro growth phenotype
of DhoasCDC1551. The genome sequence we determined for
WTCDC1551 had hundreds of differences from the published
CDC1551 reference sequence, NC_002755.2, which are assumed to
be due to corrections in original sequencing errors, including many
ambiguous nucleotides and short 1 bp indels.
4. Discussion
We began our studies of the biology of HOAS by taking advan-
tage of the availability of the transposon mutant in the CDC1551
background. We completed our in vitro studies of hoas::tnCDC1551,
hoas::tnCDC1551::hoas, DhoasCDC1551 and DhoasCDC1551::hoas before
testing the phenotype of WTCDC1551 and DhoasCDC1551 in the mouse.
The marked attenuation of WTCDC1551 in the mouse was unantici-
pated. That observation led us to conclude that a study of the
biology of HOAS in intact Mtb in vitro might be compromised in the
CDC1551 background. We therefore recapitulated our studies in the
WTH37Rv background after generating DhoasH37Rv and
DhoasH37Rv::hoas [12]. This gave us the opportunity to compare and
contrast the phenotypic consequences of identical gene deletions in
two differentMtb strainseDhoasCDC1551 andDhoasH37Rve thatwere
engineered with the same genetic tools. We believe that the dis-
crepancies we observed, while unexplained, have cautionary value.
First, we observed a startling difference in growth proﬁles for
the deletion mutants in glutamate: glutamate was suppressive for
DhoasH37Rv, but supportive for DhoasCDC1551. Glutamate also abol-
ished growth of DhoasH37Rv when added to acetate. For
DhoasCDC1551, the combination of glutamate and acetatewas growth
suppressive, but as noted, glutamate alone supported growth.
Second, growth of hoas::tnCDC1551, a strain expressing a trun-
cated version of HOAS, was defective in glycerol (as opposed to
glutamate) and this defect was not rescued by complementation.
This result was starkly different fromwhat was observed with both
deletion mutants, whose phenotypes were all complemented by
the wild type allele.
Third, in mixtures of glutamate and acetate, hoas::tnCDC1551 and
DhoasCDC1551 had opposing phenotypes, yet in each case these
particular phenotypes were normalized by genetic complementa-
tion. The genome sequences of WTH37Rv and WTCDC1551 have a
considerable number of differences, given that strains H37Rv and
CDC1551 are derived from different TB lineages (i.e. T clade versus X
clade, respectively [15,16]), including approximately 1300 SNPs
between them, as well as several inserted/deleted genes and
genomic regions. Thus there are many potential reasons why there
might be differences in phenotypes between mutants derived from
different genetic backgrounds.
In other respects, both deletion mutants exhibited similar
properties. As reported elsewhere, DhoasH37Rv was much more
susceptible to reactive nitrogen intermediates in vitro than
WTH37Rv [12]. Likewise, DhoasCDC1551 was far more susceptible to
reactive nitrogen intermediates in vitro than WTCDC1551 (data not
shown). Exposure to glutamate induced selective increases in
intracellular a-ketoglutarate and succinic semialdehyde levels
within DhoasH37Rv [12]. Levels of these same metabolites were also
selectively and extensively elevated when DhoasCDC1551 was grownin the presence of glutamate, despite this strain's lack of a growth
defect with glutamate as sole carbon source (data not shown).
Finally, both deletion mutants were attenuated in mice, although
attenuation was more severe on the CDC1551 background.
In an attempt to clarify phenotypic discrepancies between both
deletion mutants and between them and hoas::tnCDC1551, as well as
to understand why WTCDC1551 was so attenuated on its own, we
sequenced the genomes of the three mutant strains and their WT
parents. We discovered that both DhoasCDC1551 and WTH37Rv ge-
nomes contained deletions in rv2932, the gene encoding the
phthiocerol synthesis type-I polyketide synthase, PpsB, in the ppsA-
E operon that encodes enzymes vital for synthesis of phthiocerol
dimycocerosate (PDIM). PDIM is a wax in the cell wall necessary for
full virulence of Mtb strains in mice, and is frequently lost during
in vitro passage [17,18]. This polymorphism most likely contributed
to the slightly reduced CFU count we observed for WTH37Rv in
mouse lungs compared to other reports using WTH37Rv [12].
However, PDIM biosynthesis was not genetically disrupted in
WTCDC1551, whose sequence hardly differed from that of WTCDC1551
used in other laboratories. Thus PDIM deﬁciency did not seem likely
to account for our fourth surprising observation, the marked
attenuation of WTCDC1551.
Contrary to our expectations, whole genome re-sequencing re-
sults did not appear to explain the sole phenotypic discrepancy
observed in vitro (growth in glutamate) between the two hoas
deletion strains. The deletion of HOAS in DhoasH37Rv explains the
sensitivity to glutamate in an H37Rv background [12]. Relative to
this, the ability of DhoasCDC1551 to grow on glutamate was unex-
pected; however, the sole unique secondary mutation observed in
DhoasCDC1551 (compared to the parental CDC1551) was unable to
explain this anomalous phenotype. Nor did any one of the unique
polymorphisms seem likely to explain the phenotypic disparities
among DhoasCDC1551, DhoasCDC1551, and hoas::tnCDC1551. The
hoas::tnCDC1551 genome harbors only three unique mutations
compared to DhoasCDC1551, despite its unique growth proﬁle, which
suggests caution in interpreting further results with this
transposon-insertion strain.
Our observations appear to challenge the underlying premise of
genetic complementation: that restoration of WT behavior upon
supplying the WT allele establishes that a mutant's phenotype is
due speciﬁcally to disruption or deletion of the corresponding gene.
Our observations also illustrate that re-sequencing of the genome
of a mutant may not always reveal potential explanations for its
phenotype. Among speculative explanations for these observations
we suggest the following. (i) The observed polymorphisms, acting
in concert, may have epistatic effects that would be unanticipated
from the annotated function of each polymorphic gene considered
separately. (ii) There may be polymorphisms in regions of the
genome that were not well covered by sequencing. (iii) There could
be copy-number variation in tandem-repeat sequences (e.g. MIRU
sequences), which are difﬁcult to resolve with short-read
sequencing data. (iv) Single nucleotide polymorphisms that are
silent in the annotated coding region may change sense in an un-
annotated open reading frame or change function in an unanno-
tated intergenic regulatory sequence on the opposite strand. (v)
RNA editing may occur in Mtb, so that the sequence of some
transcripts may differ from the sequence encoded in the DNA. (vi)
Epigenetic changes, for example differences in DNA methylation
patterns, may affect gene expression in Mtb, leading to different
growth phenotypes [19].
5. Conclusions
This study illustrates three ﬁndings that reveal limitations in
what is currently the standard approach to mycobacterial genetics:
C. Maksymiuk et al. / Tuberculosis 95 (2015) 689e694694(i) a transposon mutant's growth proﬁle differed from that of a
deletion mutant in the same strain background, and both could be
complemented; (ii) the same gene deletion in two genetically
similar strain backgrounds gave different phenotypes, though each
could be complemented; and (iii) whole genome re-sequencing did
not provide an obvious explanation for (i) or (ii).
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